Dr. Jay Mehta is a Fremont, California based male Ophthalmologist who is specialized in Ophthalmology. Active license number of Dr. Jay Mehta is A92582 for Ophthalmology in California. Dr. Jay Mehta is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Dr. Jay Mehta speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
M.D.
Gender:
Male
Practice Address:
39263 Mission Blvd., Fremont, California, 94536
Phone:
510-796-4500
Fax:
510-796-4574
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1417905456
NPI Enumeration Date:
04 May, 2006
NPI Last Update On:
03 Sep, 2013
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Jay Mehta are as mentioned below.
License Number
Specialization
State
Status
A92582
Ophthalmology
California
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
39263 Mission Blvd., Fremont, California
Zip:
94536
Phone Number:
510-796-4500
Fax Number:
510-796-4574
Patients can reach Dr. Jay Mehta at 39263 Mission Blvd., Fremont, California or can call to book an appointment on 510-796-4500. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.